Articles Tagged With:
-
Ethical Guidance for Autism Genomics Research
Autism genomics research raises some unique ethical concerns. The story will report on new ethics recommendations.
-
Ethics Committees Are Adding Community Members
This article covers effective approaches regarding ethics committees adding community members to their ranks.
-
Doctors Pressured to Participate in Grateful Patient Fundraising
Physicians are struggling with ethical responses if asked to participate in “grateful patient” fundraising for hospitals/health systems. This article discusses a new ACEP paper that addresses this ethically controversial practice.
-
Family/Clinician Conflicts Are Top Reason for Pediatric Ethics Consults
Conflicts between family members and clinicians are the most common issue addressed during ethics consults, according to a group of researchers. This article discusses implications for clinicians and ethics consultants.
-
Avoid Liability from Patient Elopement
Patient elopement is a major threat to patient safety, particularly with the most vulnerable patients. Any resulting injury or death could bring liability to the healthcare facility. The risk requires careful adherence to proper policies and procedures, along with the use of some physical precautions that can reduce the risk of elopement.
-
Three Common Missteps to Avoid with Med Mal Cases
Medical malpractice allegations can set off a cascade of obligations and possible pitfalls, and it can seem like there is too much to handle all at once. Paying attention to three potential missteps can ease some of the burden.
-
EMTALA Still Poses Challenges After All These Years
EMTALA has encouraged the safe care of emergent patients since 1986, yet it still poses significant compliance challenges and hospitals are cited for violations. Understanding the potential pitfalls and best practices can help healthcare organizations avoid serious consequences.
-
Zilucoplan Injection (Zilbrysq)
The U.S. Food and Drug Administration has approved a once-daily subcutaneously administered drug for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive. Zilucoplan is macrocyclic peptide that inhibits the cleavage of complement 5 (C5) to C5a and C5b.
-
Brain Atrophy and Type 1 Diabetes
In a long-term longitudinal study of people with type 1 diabetes, excessive brain atrophy and cognitive dysfunction were noted compared to healthy controls. The investigators calculated that type 1 diabetes resulted in six years of accelerated brain aging and brain atrophy that was separate and distinct from Alzheimer’s disease.
-
Shigella: The New Superbug?
Five percent of Shigella isolates in the United States in 2022 were extensively drug-resistant.